Pimitespib

Pimitespib (trade name Jeselhy) is a drug for the treatment of gastrointestinal stromal tumors.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Pimitespib (trade name Jeselhy) is a drug for the treatment of gastrointestinal stromal tumors. It was discovered and developed by Taiho Pharmaceutical Co. The mechanism of action of pimitespib involves inhibition of heat shock protein 90 (Hsp90). In June 2022, it received approval in Japan for gastrointestinal stromal tumors that have progressed after chemotherapy.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1346825049 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.